Newborns Supplemented With Gentle-UHT Donor Milk
Completed · Not applicable
Conditions studied: Newborns, Breast Milk Expression
In brief
This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.
Key facts
- Study ID
- NCT04492579
- Run by
- LactaLogics, Inc
- People needed
- 31
- Starts
- 2018-08-03
- Expected to finish
- 2020-01-17
- Last updated by the study team
- 2020-07-30
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Gestational age >36 weeks
- Exclusively fed human milk
- Age <96 hours (4 days)
You may not qualify if…
- Previous admittance to the neonatal intensive care unit
- Supplementation of any formula
Where it is running
- LactaLogics, Inc. — Port Saint Lucie, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.